Cell membrance-coated nanoparticles (NPs) have been garnering increased attention due to the NPs possessing many desirable features, including red blood cell-derived NPs with long-circulatina capabilities, leukocyte membrance-coated particles with traverse endothelium abilities, cancer cell membrane-cloaked NPs with homotypic targeting properties.